Presentation TVT 2013 How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union? Presenter: A. Pieter Kappetein June 12, 2013
Presentation TVT 2013 Status Update of the PROTAVI C Trial in EU Presenter: Alec Vahanian June 12, 2013
Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 Methods and Guidelines for Optimal TAVR Annulus Sizing Presenter: Lutz Buellesfeld June 12, 2013
Presentation TVT 2013 Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights Presenter: Philip Green June 12, 2013
Presentation TVT 2013 Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates Presenter: Mathew Williams June 12, 2013
Presentation TVT 2013 Thriving and Needed More Than Ever Presenter: A. Pieter Kappetein June 12, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
Presentation TVT 2013 Optimal Femoral Access: Variations on How To Do It Presenter: William Gray June 12, 2013